Kaleido Biosciences, Inc.
KLDODelisted Apr 18, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001751299
Kaleido Biosciences, Inc. was delisted on Apr 18, 2022; its insiders filed their last Form 4 on Mar 2, 2022; 63 institutions reported holding it in 13F filings for Q1 2022, worth $55.1M in total; no superinvestor held it.
Holders of 5% or more of KLDO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Kaleido Biosciences, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Kaleido Biosciences, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Kaleido Biosciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 16, 2021 | HarbourVest Partners L.P. | 13GOld format | – | New | – | SEC |
| Feb 10, 2021 | Flagship Ventures Fund V, L.P. | 13D/AOld format | – | – | – | SEC |
| Jan 11, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Kaleido Biosciences, Inc. shares.
No Form 144 notices for Kaleido Biosciences, Inc. are on file.